DNA ploidy status - PubMed (original) (raw)

Editorial

DNA ploidy status

T A Stamey. Urology. 1995 Apr.

No abstract available

[Prostatic carcinoma: prognostic importance of nuclear DNA ploidy].
Halachmi S, Moskovitz B, Nativ O. Halachmi S, et al. Harefuah. 1995 May 15;128(10):630-3. Harefuah. 1995. PMID: 7601379 Review. Hebrew. No abstract available.
Practical clinical utility of DNA ploidy for managing patients with prostate carcinoma.
Lieber MM. Lieber MM. Urology. 1995 Apr;45(4):558-62. doi: 10.1016/S0090-4295(99)80042-9. Urology. 1995. PMID: 7716834 No abstract available.
[Morphometric diagnostics of the prostate precancer and cancer by examination of ploidy].
Gundorova LV, Avtandilov GG, Saniev KB, Zaĭrat'iants OV. Gundorova LV, et al. Arkh Patol. 2003 Jul-Aug;65(4):46-50. Arkh Patol. 2003. PMID: 14518195 Russian.
A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA. Ahlgren G, et al. Urology. 1997 Sep;50(3):379-84. doi: 10.1016/S0090-4295(97)00223-9. Urology. 1997. PMID: 9301701
Consensus review of the clinical utility of DNA content cytometry in prostate cancer.
Shankey TV, Kallioniemi OP, Koslowski JM, Lieber ML, Mayall BH, Miller G, Smith GJ. Shankey TV, et al. Cytometry. 1993;14(5):497-500. doi: 10.1002/cyto.990140508. Cytometry. 1993. PMID: 8354122 Review. No abstract available.

Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy.
Isharwal S, Miller MC, Epstein JI, Mangold LA, Humphreys E, Partin AW, Veltri RW. Isharwal S, et al. Int J Cancer. 2008 Dec 1;123(11):2636-43. doi: 10.1002/ijc.23838. Int J Cancer. 2008. PMID: 18767043 Free PMC article.